What’s new in ARDS: ARDS also exists in resource-constrained settings by unknown
Intensive Care Med (2016) 42:794–796
DOI 10.1007/s00134-016-4308-5
WHAT’S NEW IN INTENSIVE CARE
What’s new in ARDS: ARDS also exists 
in resource-constrained settings
Elisabeth D. Riviello1,2*, Luigi Pisani3,4,5 and Marcus J. Schultz5,6,7
© 2016 The Author(s) . This article is published with open access at Springerlink.com
The acute respiratory distress syndrome (ARDS) causes 
morbidity and mortality in both resource-constrained 
and resource-rich settings, but diagnosis, therapy, and 
research priorities vary with context (Fig.  1). While 
ARDS exists in resource-constrained settings, it may be 
under-recognized and under-treated, and is certainly 
under-studied. This has consequences both for current 
ARDS patient in resource-constrained settings, as well as 
future patients who could benefit from context-specific 
interventions to improve outcomes in ARDS.
The burden of ARDS in resource-constrained settings 
is  poorly understood. One study recently reported the 
incidence and outcomes of ARDS in a Rwandan hospital 
using a modified definition of ARDS [1]. The study sug-
gested that ARDS is both common and frequently lethal 
in resource-constrained settings: 4  % of adult patients 
met the modified definition of ARDS, and 50 % of these 
patients died. A direct comparison between resource-
constrained and resource-rich settings is not possible 
because of differences in methodology of the available 
studies [1–3] and predicting where ARDS might be more 
common is not straightforward. Infection and trauma 
are the leading clinical insults leading to ARDS, and 
both are more prevalent in low-income countries [1, 2, 
4]. On the other hand, ARDS could be more prevalent 
in high-income countries given evidence suggesting that 
mechanical ventilation, far more available in these set-
tings, itself contributes to the development of ARDS 
[5]. In addition, the distinction between resource-con-
strained and resource-rich settings is more complicated 
in middle-income countries where resources exist but 
access to care may be extremely variable [6].
If ARDS is so common and lethal in resource-con-
strained settings, why is the data so sparse? One reason 
is a challenge not specific to ARDS but to all critical care 
research. Critical illness studies are often confined to 
patients in intensive care units (ICUs), of which there are 
very few in poorer settings [4]. The recent Intensive Care 
Over Nations (ICON) study is a good example of a large-
scale effort to capture an international sample; yet in this 
study only 1.4  % of all patients were from the African 
continent [7]. A second reason explaining scarce ARDS 
data from resource-constrained settings is particular to 
the current Berlin definition of ARDS, which requires 
diagnostic and treatment capabilities that are almost 
universally absent in resource-limited settings [8]. Spe-
cifically, arterial blood gas analysis, which is necessary 
for calculation of the PaO2 to FiO2 ratio (P/F), and chest 
radiography, which is necessary to determine whether 
bilateral opacities are present, are often not accessible [9].
Validation of alternative criteria to the Berlin defini-
tion for ARDS could allow for better recognition and 
quantification of ARDS in resource-constrained settings. 
Lung ultrasound (US) may be easier to perform than 
chest radiography in resource-constrained settings, and 
increasing evidence suggests that lung US is at least as 
accurate as chest radiography for diagnosing ARDS [10]. 
Ultrasound can assess positive end-expiratory pressure 
(PEEP)-induced changes in lung aeration and thus has the 
potential to guide recruitment maneuvers. Furthermore, 
combining lung with bedside cardiac US can be helpful in 
differentiating ARDS from cardiogenic pulmonary edema 
and in assessing right ventricular function [11]. Advan-
tages of US are many: fast learning curves, low costs, and 
requiring only basic US technology. Affordable, hand-
held, battery-driven devices are increasingly available.
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Reasonable estimates of the P/F from SpO2 to FiO2 
ratio (S/F) have been derived from large datasets, such 
that pulse oximetry could realistically replace oxygena-
tion assessment by arterial blood gases [12]. The Rwan-
dan study mentioned above demonstrated remarkable 
consistency in ARDS incidence using a variety of FiO2 
estimates and S/F cutoffs [1]. Full validation of the Kigali 
modification of the Berlin definition for ARDS and defini-
tive validation of the S/F would allow comparisons across 
different settings worldwide. Furthermore, S/F should be 
investigated as an alternative to P/F in the mounting evi-
dence on better outcome prediction using oxygenation 
data at 24 h from ARDS diagnosis [13].
Does it matter that ARDS exists in resource-con-
strained settings but is rarely recognized? Yes. It matters 
because recognition is necessary to improve outcomes. 
First, recognition allows implementation of interven-
tions that are clearly feasible in resource-constrained 
settings, such as conservative fluid management for 
both prevention and supportive care [14]. Second, rec-
ognition allows research into the risks and benefits of 
applying interventions that are known to be effective in 
resource-rich settings but could be less safe in settings 
with fewer trained staff (Fig.  1). For example, proning 
for severe ARDS is theoretically possible given that it 
requires no particular technology; however, the abil-
ity to perform it safely with the few staff available may 
be a barrier. A trial in Bangladesh that found possible 
harm from early enteral feeding in cerebral malaria is a 
good example of the need to test interventions in both 
resource-rich and resource-constrained environments, 
where the risks and benefits may be very different [15]. 
Third, recognition allows research into ARDS triggers 
and lung injury pathways that may be different in vari-
ous contexts and populations. ARDS associated with 
malaria, HIV, or tuberculosis in Africa may represent a 
different set of molecular pathways than ARDS associ-
ated with community-acquired pneumonia in Europe. 
Incidence: probably common 
Resource–constrained setting Resource–rich setting 
Incidence: common 
Diagnosis: pulse oximetry, ultrasound Diagnosis: arterial blood gas, chest 
radiograph, CT–scan 
Outcomes: 50% mortality Outcomes: 35-50% mortality 
Feasible: 
Conservative fluid management 
Feasible: 
Conservative fluid management 
Low tidal volume ventilation 
PEEP based on esophageal pressure monitoring 
Neuromuscular blockade (severe ARDS) 
Proning (severe ARDS) 
ECMO (severe ARDS) 
Treatment of underlying causes 
Possibly feasible: 
Low tidal volume ventilation 
Neuromuscular blockade (severe ARDS) 
Proning (severe ARDS) 
Treatment of underlying causes 
Need for research into: 
Risk-benefit balance of interventions in different real-world settings 
New supportive interventions 
Treatments targeting molecular pathways of ARDS 
Role of specific potential ARDS risk factors (malaria, tuberculosis, HIV, etc.)  
Fig. 1 ARDS in resource-constrained and resource-rich settings: differences in incidence, outcomes, diagnostic approach, interventions, and 
research priorities
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Just as research in sepsis requires one to pursue targeted 
molecular therapies that include resource-limited set-
tings [16], so too does the heterogeneity of ARDS trig-
gers and presentations highlight the need for trials in 
settings beyond resource-rich countries. Finally, rec-
ognition of ARDS could contribute to improvements in 
all aspects of healthcare. A good outcome for a patient 
with ARDS caused by peritonitis requires the capacity 
for safe surgery and adequate antibiotics in addition to 
lung-protective ventilation. This sobering limitation is 
nonetheless a platform for advocacy. Just as a ‘vertical’ 
approach to improving HIV outcomes has led to a recog-
nition of a need for ‘horizontal’ health system strengthen-
ing, so too could a focus on ARDS strengthen advocacy 
for improved healthcare systems.
ARDS exists worldwide, including in resource-poor 
settings where its incidence, triggers, modifiers, and out-
comes remain largely unknown. Validation of a definition 
that can be applied in all settings, education about how 
to prevent and manage the syndrome, and research to 
expand treatment strategies are all desperately needed.
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